Unlike some of the other GLP-1 receptor agonists, this Exenatide injection requires administration twice daily
Then, the medication should continue to be taken to maintain the results and prevent weight gain
The trial failed to demonstrate any statistically significant impact of semaglutide on retinal oxygenation or vascular diameter, arguing against a direct vasotoxic mechanism
Guest Information: Alex DiFeliceantonio, Ph.D., appetitive neuroscientist, assistant professor, Fralin Biomedical Research Institute at Virginia Tech University
More than 90% of ACA plans include GLP-1 coverage for diabetes
Hashimoto's patients show higher rates of insulin resistance compared to the general population, even after thyroid hormone levels are optimized with medication